Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 507353, 9 pages
http://dx.doi.org/10.1155/2014/507353
Research Article

Relationships of Alpha-SMA-Positive Fibroblasts and SDF-1-Positive Tumor Cells with Neoangiogenesis in Nasopharyngeal Carcinoma

1Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
2Department of Otolaryngology Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, No. 22 Shuangyong Road, Nanning 530027, China
3Faculty of Nursing Science, Suzuka University of Medical Science, 3500-3 Minamitamagaki-cho, Suzuka, Mie 513-8670, Japan
4Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki-cho, Suzuka, Mie 513-8670, Japan

Received 13 December 2013; Revised 28 February 2014; Accepted 8 April 2014; Published 27 April 2014

Academic Editor: Jeroen Rouwkema

Copyright © 2014 Shumin Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kalluri, “Basement membranes: structure, assembly and role in tumour angiogenesis,” Nature Reviews Cancer, vol. 3, no. 6, pp. 422–433, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Kalluri and M. Zeisberg, “Fibroblasts in cancer,” Nature Reviews Cancer, vol. 6, no. 5, pp. 392–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Orimo, P. B. Gupta, D. C. Sgroi et al., “Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion,” Cell, vol. 121, no. 3, pp. 335–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Kryczek, A. Lange, P. Mottram et al., “CXCL12 and vascular endothelial growth factor synergistically induce neonaniogenisis in human ovarian cancers,” Cancer Research, vol. 65, no. 2, pp. 465–472, 2005. View at Google Scholar · View at Scopus
  5. Y. Gazitt and C. Akay, “Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4,” Stem Cells, vol. 22, no. 1, pp. 65–73, 2004. View at Google Scholar · View at Scopus
  6. M. B. Dwinell, H. Ogawa, K. E. Barrett, and M. F. Kagnoff, “SDF-1/CXCL12 regulates cAMP production and ion transport in intestinal epithelial cells via CXCR4,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 286, no. 5, pp. G844–G850, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. Yin, S. Miraglia, E. D. Zanjani et al., “AC133, a novel marker for human hematopoietic stem and progenitor cells,” Blood, vol. 90, no. 12, pp. 5002–5012, 1997. View at Google Scholar · View at Scopus
  8. M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000. View at Google Scholar · View at Scopus
  9. I. Flamme, G. Breier, and W. Risau, “Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo,” Developmental Biology, vol. 169, no. 2, pp. 699–712, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Ajili, M. Kacem, H. Tounsi et al., “Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34,” Ultrastructural Pathology, vol. 36, no. 5, pp. 336–342, 2012. View at Publisher · View at Google Scholar
  11. U. M. Domanska, R. C. Kruizinga, W. B. Nagengast et al., “A review on CXCR4/CXCL12 axis in oncology: no place to hide,” European Journal of Cancer, vol. 49, no. 1, pp. 219–230, 2013. View at Publisher · View at Google Scholar
  12. I. Chebib, M. T. Shabani-Rad, M. S. Chow, J. Zhang, and Z. H. Gao, “Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis,” Biomarker Insights, vol. 2, pp. 59–68, 2007. View at Google Scholar
  13. M. Toi, K. Inada, H. Suzuki, and T. Tominaga, “Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression,” Breast Cancer Research and Treatment, vol. 36, no. 2, pp. 193–204, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Roskoski Jr., “Vascular endothelial growth factor (VEGF) signaling in tumor progression,” Critical Reviews in Oncology/Hematology, vol. 62, no. 3, pp. 179–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Tao and A. T. C. Chan, “Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments,” Expert Reviews in Molecular Medicine, vol. 9, no. 12, pp. 1–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Folkman, “Tumor angiogenesis: therapeutic implications,” New England Journal of Medicine, vol. 285, no. 21, pp. 1182–1186, 1971. View at Google Scholar · View at Scopus
  17. Y. Cao, Z. L. Zhang, M. Zhou et al., “Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma,” Cancer, vol. 119, no. 2, pp. 313–324, 2013. View at Publisher · View at Google Scholar
  18. H. Fujita, K. Ohuchida, K. Mizumoto et al., “α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma,” Pancreas, vol. 39, no. 8, pp. 1254–1262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Olaso, A. Santisteban, J. Bidaurrazaga, A. M. Gressner, J. Rosenbaum, and F. Vidal-Vanaclocha, “Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis,” Hepatology, vol. 26, no. 3, pp. 634–642, 1997. View at Google Scholar · View at Scopus
  20. Y. Zhang, H. Tang, J. Cai et al., “Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion,” Cancer Letters, vol. 303, no. 1, pp. 47–55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Wu, X. Chen, Q. Zhou et al., “Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer,” Cancer Letters, vol. 335, no. 1, pp. 128–135, 2013. View at Publisher · View at Google Scholar
  22. A. Popple, L. G. Durrant, I. Spendlove et al., “The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer,” British Journal of Cancer, vol. 106, no. 7, pp. 1306–1313, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Shiozaki, T. Tabata, N. Ma et al., “Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer,” International Journal of Gynecological Cancer, vol. 23, no. 6, pp. 1111–1117, 2013. View at Publisher · View at Google Scholar
  24. B. C. Lee, T. H. Lee, S. Avraham, and H. K. Avraham, “Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells,” Molecular Cancer Research, vol. 2, no. 6, pp. 327–338, 2004. View at Google Scholar · View at Scopus
  25. J. Li, X. S. Zhang, D. Xie et al., “Expression of immune-related molecules in primary EBV positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression,” Cancer Biology and Therapy, vol. 6, no. 12, pp. 1997–2004, 2007. View at Google Scholar · View at Scopus
  26. N. Wang, Q. L. Wu, Y. Fang et al., “Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome,” Journal of Translational Medicine, vol. 3, article 26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Saigusa, Y. Toiyama, K. Tanaka et al., “Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy,” International Journal of Oncology, vol. 38, no. 3, pp. 655–663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Orimo and R. A. Weinberg, “Stromal fibroblasts in cancer: a novel tumor-promoting cell type,” Cell Cycle, vol. 5, no. 15, pp. 1597–1601, 2006. View at Google Scholar · View at Scopus
  29. L. F. Brown, A. J. Guidi, S. J. Schnitt et al., “Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast,” Clinical Cancer Research, vol. 5, no. 5, pp. 1041–1056, 1999. View at Google Scholar · View at Scopus
  30. D. Fukumura, R. Xavier, T. Sugiura et al., “Tumor induction of VEGF promoter activity in stromal cells,” Cell, vol. 94, no. 6, pp. 715–725, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. R. E. Bachelder, A. Crago, J. Chung et al., “Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells,” Cancer Research, vol. 61, no. 15, pp. 5736–5740, 2001. View at Google Scholar · View at Scopus
  32. J. F. Liang, H. K. Wang, H. Xiao et al., “Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. O. van Trappen, D. Steele, D. G. Lowe et al., “Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis,” Journal of Pathology, vol. 201, no. 4, pp. 544–554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Lyden, K. Hattori, S. Dias et al., “Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth,” Nature Medicine, vol. 7, no. 11, pp. 1194–1201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Heissig, K. Hattori, S. Dias et al., “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand,” Cell, vol. 109, no. 5, pp. 625–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. H. S. Hwang, Y. S. Maeng, Y. H. Kim, Y. G. Kwon, Y. W. Park, and I. K. Kim, “Nestin expression during differentiation of fetal endothelial progenitor cells and hypoxic culture of human umbilical vein endothelial cells,” Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 6, pp. 643–651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Patenaude, J. Parker, and A. Karsan, “Involvement of endothelial progenitor cells in tumor vascularization,” Microvascular Research, vol. 79, no. 3, pp. 217–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. T. W. Chen, Z. G. Yang, Q. L. Wang, Y. Li, L. L. Qian, and H. J. Chen, “Whole tumour quantitative measurement of first-pass perfusion of oesophageal squamous cell carcinoma using 64-row multidetector computed tomography: correlation with microvessel density,” European Journal of Radiology, vol. 79, no. 2, pp. 218–223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. N. Qian, D. Huang, B. Wondergem, and B. T. Teh, “Complexity of tumor vasculature in clear cell renal cell carcinoma,” Cancer, vol. 115, no. 10, pp. 2282–2289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Ö. Elpek, T. Gelen, N. H. Aksoy et al., “The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus,” Journal of Clinical Pathology, vol. 54, no. 12, pp. 940–944, 2001. View at Google Scholar · View at Scopus
  42. A. Gadducci, P. Viacava, S. Cosio et al., “Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma,” Anticancer Research B, vol. 23, no. 1, pp. 549–556, 2003. View at Google Scholar · View at Scopus
  43. R. L. Foote, N. Weidner, J. Harris et al., “Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505,” International Journal of Radiation Oncology Biology Physics, vol. 61, no. 3, pp. 745–753, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. E. Kountakis, Encyclopedia of Otolaryngology, Head and Neck Surgery, Springer, 2013.
  45. Y. Shaked and R. S. Kerbel, “Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy,” Cancer Research, vol. 67, no. 15, pp. 7055–7058, 2007. View at Publisher · View at Google Scholar · View at Scopus